Stockhead on MSN
Entropy’s psilocybin therapy shows rapid and sustained reduction of binge eating in 100pc of patients
Entropy Neurodynamics has received positive Phase 2a results for its psilocybin-based therapy in patients with Binge Eating ...
Tryptamine Therapeutics ( (AU:ENP)) has issued an update. Entropy Neurodynamics Limited has successfully completed the first patient dosing in its clinical trial for treating Binge Eating Disorder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback